MYGN

#4875
Myriad Genetics, Inc. - Common Stock
0.0 4 USD
-99.06%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.04
0.04
Range Annuel
0.04
8.50
Changement quotidien
-99.06%
Changement Mensuel
-99.15%
Evolution sur 6 mois
-99.47%
Changement Annuel
-99.52%
Clôture Précédente
4.2 2
Open
0.0 4
Low
0.0 4
High
0.0 4
Volume
448
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 3.75 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.56
ratio cours/chiffre d'affaires
0.69

Myriad Genetics, Inc. - Common Stock

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Nouvelles